Prospective multicentre study of indications for surgery in patients with idiopathic acute pancreatitis following endoscopic ultrasonography (PICUS).


Journal

The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553

Informations de publication

Date de publication:
09 11 2023
Historique:
received: 08 08 2023
revised: 21 08 2023
accepted: 30 08 2023
medline: 13 11 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: ppublish

Résumé

Cholecystectomy in patients with idiopathic acute pancreatitis (IAP) is controversial. A randomized trial found cholecystectomy to reduce the recurrence rate of IAP but did not include preoperative endoscopic ultrasonography (EUS). As EUS is effective in detecting gallstone disease, cholecystectomy may be indicated only in patients with gallstone disease. This study aimed to determine the diagnostic value of EUS in patients with IAP, and the rate of recurrent pancreatitis in patients in whom EUS could not determine the aetiology (EUS-negative IAP). This prospective multicentre cohort study included patients with a first episode of IAP who underwent outpatient EUS. The primary outcome was detection of aetiology by EUS. Secondary outcomes included adverse events after EUS, recurrence of pancreatitis, and quality of life during 1-year follow-up. After screening 957 consecutive patients with acute pancreatitis from 24 centres, 105 patients with IAP were included and underwent EUS. In 34 patients (32 per cent), EUS detected an aetiology: (micro)lithiasis and biliary sludge (23.8 per cent), chronic pancreatitis (6.7 per cent), and neoplasms (2.9 per cent); 2 of the latter patients underwent pancreatoduodenectomy. During 1-year follow-up, the pancreatitis recurrence rate was 17 per cent (12 of 71) among patients with EUS-negative IAP versus 6 per cent (2 of 34) among those with positive EUS. Recurrent pancreatitis was associated with poorer quality of life. EUS detected an aetiology in a one-third of patients with a first episode of IAP, requiring mostly cholecystectomy or pancreatoduodenectomy. The role of cholecystectomy in patients with EUS-negative IAP remains uncertain and warrants further study. Some patients develop acute inflammation of the pancreas without a clear cause. These patients have a high risk of developing more episodes of acute inflammation of the pancreas. Potentially, such inflammation could be caused by tiny gallstones that physicians are not able to detect. If this is true, these patients may also benefit from surgical removal of the gallbladder. However, this is still controversial. Endoscopic ultrasonography is a diagnostic procedure during which a physician looks at the gallbladder and bile ducts in detail via a small ultrasound probe inserted through the mouth. This endoscopic ultrasonography may be able to detect gallstones better than physicians were able to previously. This study tested the value of endoscopic ultrasonography, and the number of patients who developed more episodes of acute inflammation after endoscopic ultrasonography was recorded. Some 106 patients with acute inflammation of the pancreas for the first time without a clear cause participated and were offered endoscopic ultrasonography. The number of times endoscopic ultrasonography found a cause for the acute inflammation was recorded, as well as safety parameters, number of patients who developed more episodes of acute inflammation, and quality of life. After screening 957 patients, 105 ultimately underwent endoscopic ultrasonography. A cause was found in one-third of patients. This was mostly (tiny) gallstones, but chronic inflammation and even tumours were found. These patients were mostly treated surgically for their gallstones and tumours. In the first year after the first acute episode of inflammation, the inflammation came back at least once in almost one in six patients in whom endoscopic ultrasonography did not find a cause. This occurred less in patients in whom a cause was found; the inflammation came back in 1 in 16 of these patients. It was also found that having inflammation coming back negatively affected quality of life. In this study, endoscopic ultrasonography was able to detect a cause in one-third of patients with first-time acute inflammation of the pancreas. In one in four patients, this cause could be treated by a surgical procedure. Whether surgical removal of the gallbladder can be helpful in patients in whom endoscopic ultrasonography is not able to detect an aetiology should be investigated in further studies.

Sections du résumé

BACKGROUND
Cholecystectomy in patients with idiopathic acute pancreatitis (IAP) is controversial. A randomized trial found cholecystectomy to reduce the recurrence rate of IAP but did not include preoperative endoscopic ultrasonography (EUS). As EUS is effective in detecting gallstone disease, cholecystectomy may be indicated only in patients with gallstone disease. This study aimed to determine the diagnostic value of EUS in patients with IAP, and the rate of recurrent pancreatitis in patients in whom EUS could not determine the aetiology (EUS-negative IAP).
METHODS
This prospective multicentre cohort study included patients with a first episode of IAP who underwent outpatient EUS. The primary outcome was detection of aetiology by EUS. Secondary outcomes included adverse events after EUS, recurrence of pancreatitis, and quality of life during 1-year follow-up.
RESULTS
After screening 957 consecutive patients with acute pancreatitis from 24 centres, 105 patients with IAP were included and underwent EUS. In 34 patients (32 per cent), EUS detected an aetiology: (micro)lithiasis and biliary sludge (23.8 per cent), chronic pancreatitis (6.7 per cent), and neoplasms (2.9 per cent); 2 of the latter patients underwent pancreatoduodenectomy. During 1-year follow-up, the pancreatitis recurrence rate was 17 per cent (12 of 71) among patients with EUS-negative IAP versus 6 per cent (2 of 34) among those with positive EUS. Recurrent pancreatitis was associated with poorer quality of life.
CONCLUSION
EUS detected an aetiology in a one-third of patients with a first episode of IAP, requiring mostly cholecystectomy or pancreatoduodenectomy. The role of cholecystectomy in patients with EUS-negative IAP remains uncertain and warrants further study.
Some patients develop acute inflammation of the pancreas without a clear cause. These patients have a high risk of developing more episodes of acute inflammation of the pancreas. Potentially, such inflammation could be caused by tiny gallstones that physicians are not able to detect. If this is true, these patients may also benefit from surgical removal of the gallbladder. However, this is still controversial. Endoscopic ultrasonography is a diagnostic procedure during which a physician looks at the gallbladder and bile ducts in detail via a small ultrasound probe inserted through the mouth. This endoscopic ultrasonography may be able to detect gallstones better than physicians were able to previously. This study tested the value of endoscopic ultrasonography, and the number of patients who developed more episodes of acute inflammation after endoscopic ultrasonography was recorded. Some 106 patients with acute inflammation of the pancreas for the first time without a clear cause participated and were offered endoscopic ultrasonography. The number of times endoscopic ultrasonography found a cause for the acute inflammation was recorded, as well as safety parameters, number of patients who developed more episodes of acute inflammation, and quality of life. After screening 957 patients, 105 ultimately underwent endoscopic ultrasonography. A cause was found in one-third of patients. This was mostly (tiny) gallstones, but chronic inflammation and even tumours were found. These patients were mostly treated surgically for their gallstones and tumours. In the first year after the first acute episode of inflammation, the inflammation came back at least once in almost one in six patients in whom endoscopic ultrasonography did not find a cause. This occurred less in patients in whom a cause was found; the inflammation came back in 1 in 16 of these patients. It was also found that having inflammation coming back negatively affected quality of life. In this study, endoscopic ultrasonography was able to detect a cause in one-third of patients with first-time acute inflammation of the pancreas. In one in four patients, this cause could be treated by a surgical procedure. Whether surgical removal of the gallbladder can be helpful in patients in whom endoscopic ultrasonography is not able to detect an aetiology should be investigated in further studies.

Autres résumés

Type: plain-language-summary (eng)
Some patients develop acute inflammation of the pancreas without a clear cause. These patients have a high risk of developing more episodes of acute inflammation of the pancreas. Potentially, such inflammation could be caused by tiny gallstones that physicians are not able to detect. If this is true, these patients may also benefit from surgical removal of the gallbladder. However, this is still controversial. Endoscopic ultrasonography is a diagnostic procedure during which a physician looks at the gallbladder and bile ducts in detail via a small ultrasound probe inserted through the mouth. This endoscopic ultrasonography may be able to detect gallstones better than physicians were able to previously. This study tested the value of endoscopic ultrasonography, and the number of patients who developed more episodes of acute inflammation after endoscopic ultrasonography was recorded. Some 106 patients with acute inflammation of the pancreas for the first time without a clear cause participated and were offered endoscopic ultrasonography. The number of times endoscopic ultrasonography found a cause for the acute inflammation was recorded, as well as safety parameters, number of patients who developed more episodes of acute inflammation, and quality of life. After screening 957 patients, 105 ultimately underwent endoscopic ultrasonography. A cause was found in one-third of patients. This was mostly (tiny) gallstones, but chronic inflammation and even tumours were found. These patients were mostly treated surgically for their gallstones and tumours. In the first year after the first acute episode of inflammation, the inflammation came back at least once in almost one in six patients in whom endoscopic ultrasonography did not find a cause. This occurred less in patients in whom a cause was found; the inflammation came back in 1 in 16 of these patients. It was also found that having inflammation coming back negatively affected quality of life. In this study, endoscopic ultrasonography was able to detect a cause in one-third of patients with first-time acute inflammation of the pancreas. In one in four patients, this cause could be treated by a surgical procedure. Whether surgical removal of the gallbladder can be helpful in patients in whom endoscopic ultrasonography is not able to detect an aetiology should be investigated in further studies.

Identifiants

pubmed: 37811814
pii: 7301266
doi: 10.1093/bjs/znad318
pmc: PMC10638543
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1877-1882

Subventions

Organisme : Dutch Digestive Disease Foundation
ID : D17-25

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of BJS Society Ltd.

Références

United European Gastroenterol J. 2020 Apr;8(3):340-350
pubmed: 32213015
Gut. 2013 Jan;62(1):102-11
pubmed: 23100216
Curr Gastroenterol Rep. 2011 Apr;13(2):150-6
pubmed: 21222060
Ann Surg. 2015 Nov;262(5):736-41
pubmed: 26583660
Ann Surg. 2017 Dec;266(6):e94-e95
pubmed: 27058949
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Scand J Gastroenterol. 2010 Mar;45(3):375-81
pubmed: 20034361
J Gastroenterol. 2007 Feb;42(2):101-19
pubmed: 17351799
BMJ Open. 2020 Aug 20;10(8):e035504
pubmed: 32819938
Clin Chem. 2003 Jan;49(1):1-6
pubmed: 12507953
Pancreatology. 2013 Jul-Aug;13(4 Suppl 2):e1-15
pubmed: 24054878
Br J Surg. 2020 Feb;107(3):191-199
pubmed: 31875953
Gut. 2005 May;54 Suppl 3:iii1-9
pubmed: 15831893
Am J Gastroenterol. 2006 Oct;101(10):2379-400
pubmed: 17032204
Pancreatology. 2017 Mar - Apr;17(2):155-165
pubmed: 28159463
Am J Gastroenterol. 2013 Sep;108(9):1400-15; 1416
pubmed: 23896955
Anesth Analg. 2018 Aug;127(2):569-575
pubmed: 29905618
Int J Surg. 2015 Nov;23(Pt A):68-74
pubmed: 26384834
Gastrointest Endosc. 2004 Nov;60(5):673-8
pubmed: 15557941
Endoscopy. 2020 Nov;52(11):955-964
pubmed: 32557477
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131

Auteurs

Devica S Umans (DS)

Department of Gastroenterology and Hepatology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Research and Development, St Antonius Hospital, Nieuwegein, the Netherlands.

Hester C Timmerhuis (HC)

Department of Research and Development, St Antonius Hospital, Nieuwegein, the Netherlands.
Department of Surgery, St Antonius Hospital, Nieuwegein, the Netherlands.

Marie-Paule G F Anten (MGF)

Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland, Rotterdam, the Netherlands.

Abha Bhalla (A)

Department of Gastroenterology and Hepatology, Haga Hospital, The Hague, the Netherlands.

Rina A Bijlsma (RA)

Department of Gastroenterology and Hepatology, Martini Hospital, Groningen, the Netherlands.

Lotte Boxhoorn (L)

Department of Gastroenterology and Hepatology, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.
Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Research and Development, St Antonius Hospital, Nieuwegein, the Netherlands.

Menno A Brink (MA)

Department of Gastroenterology and Hepatology, Meander Medical Centre, Amersfoort, the Netherlands.

Marco J Bruno (MJ)

Department of Gastroenterology and Hepatology, Erasmus Medical Centre, Rotterdam, the Netherlands.

Wouter L Curvers (WL)

Department of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.

Brechje C van Eijck (BC)

Department of Gastroenterology and Hepatology, Spaarne Gasthuis, Haarlem, the Netherlands.

G Willemien Erkelens (GW)

Department of Gastroenterology and Hepatology, Gelre Hospital, Apeldoorn, the Netherlands.

Erwin J M van Geenen (EJM)

Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands.

Wouter L Hazen (WL)

Department of Gastroenterology and Hepatology, Elisabeth-Tweesteden Hospital, Tilburg, the Netherlands.

Chantal V Hoge (CV)

Department of Gastroenterology and Hepatology, Maastricht University Medical Centre, Maastricht, the Netherlands.

Lieke Hol (L)

Department of Gastroenterology and Hepatology, Maasstad Hospital, Rotterdam, the Netherlands.

Akin Inderson (A)

Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.

Liesbeth M Kager (LM)

Department of Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands.

Sjoerd D Kuiken (SD)

Department of Gastroenterology and Hepatology, OLVG, Amsterdam, the Netherlands.

Lars E Perk (LE)

Department of Gastroenterology and Hepatology, Medical Centre Haaglanden, The Hague, the Netherlands.

Rutger Quispel (R)

Department of Gastroenterology and Hepatology, Reinier de Graaf Gasthuis, Delft, the Netherlands.

Tessa E H Römkens (TEH)

Department of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, the Netherlands.

Christina J Sperna Weiland (CJ)

Department of Research and Development, St Antonius Hospital, Nieuwegein, the Netherlands.
Department of Gastroenterology and Hepatology, Radboud University Medical Centre, Nijmegen, the Netherlands.

Annemieke Y Thijssen (AY)

Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.

Niels G Venneman (NG)

Department of Gastroenterology and Hepatology, Medisch Spectrum Twente, Enschede, the Netherlands.

Robert C Verdonk (RC)

Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, the Netherlands.

Roy L J van Wanrooij (RLJ)

Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Gastroenterology and Hepatology, Amsterdam UMC, location Vrije Universiteit, Amsterdam, the Netherlands.

Ben J Witteman (BJ)

Department of Gastroenterology and Hepatology, Hospital Gelderse Vallei, Ede, the Netherlands.

Marc G Besselink (MG)

Amsterdam Gastroenterology, Endocrinology and Metabolism, Amsterdam UMC, Amsterdam, The Netherlands.
Department of Surgery, Amsterdam UMC, location University of Amsterdam, Amsterdam, the Netherlands.

Jeanin E van Hooft (JE)

Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH